The Adipose-derived Stem Cell Market is entering a phase of unprecedented growth, with projections indicating a shift from a valuation of $1.30 billion in 2025 to a staggering $7.03 billion by 2035. This trajectory represents an impressive CAGR of 18.41%, showcasing the increasing share of adipose-derived stem cells in therapeutic applications. As regenerative medicine continues to gain...